Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Haluska, FG' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 32 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kilbridge, KL; Weeks, JC; Sober, AJ; Haluska, FG; Slingluff, CL; Atkins, MB; Sock, DE; Kirkwood, JM; Nease, RF
      Patient preferences for adjuvant interferon alfa-2b treatment

      JOURNAL OF CLINICAL ONCOLOGY
    2. Jonasch, E; Kumar, UN; Linette, GP; Hodi, FS; Soiffer, RJ; Ryan, BF; Sober, AJ; Mihm, MC; Tsao, H; Langley, RG; Cosimi, BA; Gadd, MA; Tanabe, KK; Souba, W; Haynes, HA; Barnhill, R; Osteen, R; Haluska, FG
      Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma

      CANCER JOURNAL
    3. Linette, GP; Shankara, S; Longerich, S; Yang, SX; Doll, R; Nicolette, C; Preffer, FI; Roberts, BL; Haluska, FG
      In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A*0201-restricted CD8(+) T cells in patients with melanoma

      JOURNAL OF IMMUNOLOGY
    4. Yang, SX; Linette, GP; Longerich, S; Roberts, BL; Haluska, FG
      HLA-A2.1/K-b transgenic murine dendritic cells transduced with an adenovirus encoding human gp100 process the same A2.1-restricted peptide epitopes as human antigen-presenting cells and elicit A2.1-restricted peptide-specific CTL

      CELLULAR IMMUNOLOGY
    5. Tsao, H; Zhang, X; Fowlkes, K; Haluska, FG
      Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines

      CANCER RESEARCH
    6. Greenberg, DB; Jonasch, E; Gadd, MA; Ryan, BF; Everett, JR; Sober, AJ; Mihm, MA; Tanabe, KK; Ott, M; Haluska, FG
      Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes - Gabapentin may serve as a mood stabilizer

      CANCER
    7. Tsao, H; Zhang, X; Kwitkiwski, K; Finkelstein, DM; Sober, AJ; Haluska, FG
      Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma

      ARCHIVES OF DERMATOLOGY
    8. Velculescu, VE; Madden, SL; Zhang, L; Lash, AE; Yu, J; Rago, C; Lal, A; Wang, CJ; Beaudry, GA; Ciriello, KM; Cook, BP; Dufault, MR; Ferguson, AT; Gao, YH; He, TC; Hermeking, H; Hiraldo, SK; Hwang, PM; Lopez, MA; Luderer, HF; Mathews, B; Petroziello, JM; Polyak, K; Zawel, L; Zhang, W; Zhang, XM; Zhou, W; Haluska, FG; Jen, J; Sukumar, S; Landes, GM; Riggins, GJ; Vogelstein, B; Kinzler, KW
      Analysis of human transcriptomes

      NATURE GENETICS
    9. Syngal, S; Kaptain, S; O'Neill, MJ; Isselbacher, KJ; Sober, AJ; Chung, DC; Haluska, FG
      A 50-year-old woman with severe diarrhea during radiation treatment for resected metastatic melanoma Cutaneous melanoma metastasized to the gastrointestinal tract, with protein-losing enteropathy. Adrenal cortical adenoma.

      NEW ENGLAND JOURNAL OF MEDICINE
    10. Tsao, H; Zhang, X; Majewski, P; Haluska, FG
      Mutational and expression analysis of the p73 gene in melanoma cell lines

      CANCER RESEARCH
    11. Zhang, X; Tsao, H; Tsuji, T; Minoshima, S; McBride, J; Majewski, P; Todd, R; Shimizu, N; Wong, DTW; Housman, DE; Haluska, FG
      Identification and mutation analysis of DOC-1R, a DOC-1 growth suppressor-related gene

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    12. Gadd, MA; Cosimi, AB; Yu, J; Duncan, LM; Yu, L; Flotte, TJ; Souba, WW; Ott, MJ; Wong, LS; Sober, AJ; Mihm, MC; Haluska, FG; Tanabe, KK
      Outcome of patients with melanoma and histologically negative sentinel lymph nodes

      ARCHIVES OF SURGERY
    13. TSAO HS; ZHANG X; BENOIT E; HALUSKA FG
      IDENTIFICATION OF PTEN MMAC1 ALTERATIONS IN UNCULTURED MELANOMAS AND MELANOMA CELL-LINES/

      Oncogene
    14. DAHIA PLM; FITZGERALD MG; ZHANG X; MARSH DJ; ZHENG ZM; PIETSCH T; VONDEIMLING A; HALUSKA FG; HABER DA; ENG C
      A HIGHLY CONSERVED PROCESSED PTEN PSEUDOGENE IS LOCATED ON CHROMOSOMEBAND 9P21

      Oncogene
    15. HALUSKA FG
      ADJUVANT INTERFERON FOR STAGE-II MELANOMA

      Journal of clinical oncology
    16. HALUSKA FG; HODI FS
      MOLECULAR-GENETICS OF FAMILIAL CUTANEOUS MELANOMA

      Journal of clinical oncology
    17. TSAO H; BENOIT E; SOBER AJ; THIELE C; HALUSKA FG
      NOVEL MUTATIONS IN THE P16 CDKN2A BINDING REGION OF THE CYCLIN-DEPENDENT KINASE-4 GENE/

      Cancer research
    18. CHABNER BA; HALUSKA FG; TALCOTT JA
      SCREENING STRATEGIES FOR CANCER - IMPLICATIONS AND RESULTS

      JAMA, the journal of the American Medical Association
    19. HALUSKA FG; THIELE C; GOLDSTEIN A; TSAO H; BENOIT EP; HOUSMAN D
      LACK OF PHOSPHOLIPASE A(2) MUTATIONS IN NEUROBLASTOMA, MELANOMA AND COLON-CANCER CELL-LINES

      International journal of cancer
    20. TSENG JF; TANABE KK; GADD MA; COSIMI AB; MALT RA; HALUSKA FG; MIHM MC; SOBER AJ; SOUBA WW
      SURGICAL-MANAGEMENT OF PRIMARY CUTANEOUS MELANOMAS OF THE HANDS AND FEET

      Annals of surgery
    21. BENOIT E; TSAO H; DRYJA TP; HALUSKA FG
      RETINOBLASTOMA TUMORS LACKING IDENTIFIED RB1 ALTERATIONS DO NOT CARRYMUTATIONS IN P16 CDKN2A OR CDK4, OTHER ELEMENTS OF THE PRB PATHWAY/

      American journal of human genetics
    22. HALUSKA FG; BENOIT E; HUEBNER K; HABER D; TSAO H
      INVOLVEMENT OF THE NOVEL TUMOR-SUPPRESSOR PTEN IN THE PATHOGENESIS OFMALIGNANT-MELANOMA

      American journal of human genetics
    23. TSAO H; BENOIT E; HUEBNER K; THIELE C; HALUSKA FG
      IDENTIFICATION OF NOVEL MUTATIONS IN THE EXON OF CDK4 CONTAINING THE P16-BINDING REGION

      American journal of human genetics
    24. FLORES JF; WALKER GJ; GLENDENING JM; HALUSKA FG; CASTRESANA JS; RUBIO MP; PASTORFIDE GC; BOYER LA; KAO WH; BULYK ML; BARNHILL RL; HAYWARD NK; HOUSMAN DE; FOUNTAIN JW
      LOSS OF THE P16(INK4A) AND P15(INK4B) GENES, AS WELL AS NEIGHBORING 9P21 MARKERS, IN SPORADIC MELANOMA

      Cancer research
    25. WALKER GJ; HUSSUSSIAN CJ; FLORE JF; GLENDENING JM; HALUSKA FG; DRACOPOLI NC; HAYWARD NK; FOUNTAIN JW
      MUTATIONS OF THE CDKN2 P16(INK4) GENE IN AUSTRALIAN MELANOMA KINDREDS/

      Human molecular genetics
    26. HSU SY; KUBO M; CHUN SY; HALUSKA FG; HOUSMAN DE; HSUEH AJW
      WILMS-TUMOR PROTEIN WT1 AS AN OVARIAN TRANSCRIPTION FACTOR - DECREASES IN EXPRESSION DURING FOLLICLE DEVELOPMENT AND REPRESSION OF INHIBIN-ALPHA GENE PROMOTER

      Molecular endocrinology
    27. HALUSKA FG; HOUSMAN DE
      RECENT ADVANCES IN THE MOLECULAR-GENETICS OF MALIGNANT-MELANOMA

      Cancer surveys
    28. REED JA; LOGANZO F; SHEA CR; WALKER GJ; FLORES JF; GLENDENING JM; BOGDANY JK; SHIEL MJ; HALUSKA FG; FOUNTAIN JW; ALBINO AP
      LOSS OF EXPRESSION OF THE P16 CYCLIN-DEPENDENT KINASE INHIBITOR 2 TUMOR-SUPPRESSOR GENE IN MELANOCYTIC LESIONS CORRELATES WITH INVASIVE STAGE OF TUMOR PROGRESSION/

      Cancer research
    29. HALUSKA FG; BRUFSKY AM; CANELLOS GP
      THE CELLULAR BIOLOGY OF THE REED-STERNBERG CELL

      Blood
    30. FOUNTAIN JW; HALUSKA FG; GRAW SL; KAO WH; GITAI Z; BOYER L; BARNHILL R; HAYWARD NK; DRACOPOLI NC; HOUSMAN DE
      TOWARDS CLONING THE MELANOMA-ASSOCIATED TUMOR-SUPPRESSOR LOCUS ON CHROMOSOME-9P21

      Cytogenetics and cell genetics
    31. FOUNTAIN JW; HALUSKA FG; GRAW SL; KAO WH; GITAI Z; BOYER LA; CASTRESANA JS; RUBIO MP; SEIZINGER B; BARNHILL R; WALKER GJ; HAYWARD NK; HOUSMAN DE
      MORE PRECISE DEFINITION OF THE 9P21 REGION LOST IN MELANOMA AND IDENTIFICATION OF A CANDIDATE GENE

      American journal of human genetics
    32. HALUSKA FG; GITAL Z; KAO W; HOUSMAN DE; FOUNTAIN JW
      CONSTRUCTION OF YAC CONTIGS SPANNING THE 9P21 REGION IMPLICATED IN MALIGNANT-MELANOMA

      American journal of human genetics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/21 alle ore 01:58:32